Semaglutide, the medication prescribed under the brand names Ozempic, for treating Type 2 diabetes, and Wegovy, for weight management, works by mimicking the hormone GLP-1, which is released by the gut after eating
It has been nearly two weeks since the semaglutide patent expired, and Indias weight-loss drug market is already opening up to cheaper generics
The glucagon receptor sets retatrutide apart from earlier peptides: glucagon activity raises energy expenditure and promotes lipolysis, so the body burns more stored fat rather than only eating less
A small plastic container or bin works well for keeping medication organized and separated
A spokesperson for Willow said the company connects patients with licensed physicians who make independent clinical judgments to help those patients achieve their health goals. The CEOs of telehealth companies themselves say they take GLP-1s despite not having obesity